For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251006:nRSF2109Ca&default-theme=true
RNS Number : 2109C Prudential PLC 06 October 2025
PRUDENTIAL PLC (the "Company")
DISCLOSURE OF DIRECTOR'S DETAILS - CLAUDIA SUESSMUTH-DYCKERHOFF
Director's other publicly quoted directorships - notification under LR
6.4.9(2)
Prudential plc confirms that Claudia Suessmuth-Dyckerhoff, Independent
Non-executive Director of the Company, has been nominated as an Independent
Member of the Board of Lonza Group Ltd ("Lonza"), subject to her election at
the Annual General Meeting of Lonza in May 2026.
About Prudential plc
Prudential provides life and health insurance and asset management in Greater
China, ASEAN, India and Africa. Prudential's mission is to be the most trusted
partner and protector for this generation and generations to come, by
providing simple and accessible financial and health solutions. The business
has dual primary listings on the Stock Exchange of Hong Kong (HKEX: 2378) and
the London Stock Exchange (LSE: PRU). It also has a secondary listing on the
Singapore Stock Exchange (SGX: K6S) and a listing on the New York Stock
Exchange (NYSE: PUK) in the form of American Depositary Receipts. It is a
constituent of the Hang Seng Composite Index and is also included for trading
in the Shenzhen-Hong Kong Stock Connect programme and the Shanghai-Hong Kong
Stock Connect programme.
Prudential is not affiliated in any manner with Prudential Financial, Inc. a
company whose principal place of business is in the United States of America,
nor with The Prudential Assurance Company Limited, a subsidiary of M&G
plc, a company incorporated in the United Kingdom.
www.prudentialplc.com (www.prudentialplc.com)
Contact
Tom Clarkson, Company Secretary, +44 (0)20 3977 9172
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RDNFIFSAIALRIIE